University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Dr. Rachael Gordon is an Assistant Professor at the University of Pittsburgh (UPitt) School of Medicine. Over the past decade and a half, Dr. Gordon has spearheaded both human and murine studies aimed at understanding how dysregulation of the immune system contributes to the pathogenesis of rheumatoid arthritis, systemic lupus erythematosus (SLE), and most recently, Sjogren’s Disease (SjD). After completing her BA at the University of Pennsylvania, she pursued an MD-PhD at UPitt under the mentorship of Dr. Mark Shlomchik. Her graduate work focused on understanding the roles of neutrophil extracellular traps, NADPH oxidase, and endosomal Toll-like receptor signaling in SLE pathogenesis. Dr. Gordon is a recent graduate of the ABIM Research Pathway at UPMC, where she completed her internal medicine residency and rheumatology fellowship.
Early in her rheumatology training, Dr. Gordon recognized that the immunology of SjD is both captivating and understudied. There are no FDA-approved disease-modifying treatments for SjD. To address this critical need, Dr. Gordon is building a Sjogren’s Center and a translational research program at UPitt, which includes a longitudinal registry and biospecimen repository. The first arm of her research program will explore the role of IL-12 in SjD pathogenesis. Dr. Gordon has been awarded the Sjögren's Foundation Pilot Grant, the RRF Scientific Development Award, and the NIH BIRCWH K12 Scholar position to start her research program.
Decoding Sjögren's Disease: Adaptive Immunity Driving Pathogenesis
Wednesday, October 29, 2025
10:00 AM – 11:00 AM Central Time
Disclosure(s): Novartis: Consultant (Ongoing)
